ATE269062T1 - Zeitgesteuert freisetzende dosierungsformen enthaltend ein kurz wirksames hypnotikum oder ein salz davon - Google Patents
Zeitgesteuert freisetzende dosierungsformen enthaltend ein kurz wirksames hypnotikum oder ein salz davonInfo
- Publication number
- ATE269062T1 ATE269062T1 AT00954518T AT00954518T ATE269062T1 AT E269062 T1 ATE269062 T1 AT E269062T1 AT 00954518 T AT00954518 T AT 00954518T AT 00954518 T AT00954518 T AT 00954518T AT E269062 T1 ATE269062 T1 AT E269062T1
- Authority
- AT
- Austria
- Prior art keywords
- salt
- short
- time
- dosage forms
- release dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99401605A EP1064937A1 (de) | 1999-06-28 | 1999-06-28 | Pharmazeutische Zusammensetzungen mit kontrollierten Freigabe enthaltend ein Hypnotikum mit kurzer Wirkung oder deren Salze |
PCT/EP2000/006792 WO2001000181A2 (en) | 1999-06-28 | 2000-06-27 | Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE269062T1 true ATE269062T1 (de) | 2004-07-15 |
Family
ID=8242028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00954518T ATE269062T1 (de) | 1999-06-28 | 2000-06-27 | Zeitgesteuert freisetzende dosierungsformen enthaltend ein kurz wirksames hypnotikum oder ein salz davon |
Country Status (28)
Country | Link |
---|---|
EP (2) | EP1064937A1 (de) |
JP (1) | JP2003503340A (de) |
KR (1) | KR20020015064A (de) |
CN (1) | CN100415216C (de) |
AR (1) | AR024491A1 (de) |
AT (1) | ATE269062T1 (de) |
AU (1) | AU782162B2 (de) |
BR (1) | BR0011994A (de) |
CA (1) | CA2370556C (de) |
CO (1) | CO5190680A1 (de) |
CZ (1) | CZ20014640A3 (de) |
DE (1) | DE60011617T2 (de) |
DK (1) | DK1194132T3 (de) |
ES (1) | ES2222223T3 (de) |
HK (1) | HK1043057B (de) |
HU (1) | HU227810B1 (de) |
IL (1) | IL146928A0 (de) |
MX (1) | MXPA01013212A (de) |
NO (1) | NO20016283L (de) |
NZ (1) | NZ515997A (de) |
PL (1) | PL201777B1 (de) |
PT (1) | PT1194132E (de) |
SI (1) | SI1194132T1 (de) |
SK (1) | SK285347B6 (de) |
TR (1) | TR200103594T2 (de) |
TW (1) | TWI285118B (de) |
WO (1) | WO2001000181A2 (de) |
ZA (1) | ZA200110005B (de) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001013895A2 (en) * | 1999-08-26 | 2001-03-01 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
US6485746B1 (en) | 2000-08-25 | 2002-11-26 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
US7811557B1 (en) * | 2000-10-27 | 2010-10-12 | Viacell, Inc. | Methods for improving central nervous system functioning |
NZ529308A (en) * | 2001-04-05 | 2005-03-24 | Collagenex Pharm Inc | Tetracycline compounds comprising a tetracycline and a controlled release agent to provide delivery at a dose below that required for antibiotic activity |
EP1406630A1 (de) | 2001-07-06 | 2004-04-14 | Endo Pharmaceuticals Inc. | Parenterale verabreichung von hydroxy-oxymorphon als analgetikum |
US8329216B2 (en) | 2001-07-06 | 2012-12-11 | Endo Pharmaceuticals Inc. | Oxymorphone controlled release formulations |
JP4417110B2 (ja) * | 2001-12-19 | 2010-02-17 | 株式会社三和化学研究所 | 放出制御型成型品 |
EP1941878A1 (de) * | 2002-01-10 | 2008-07-09 | Biovail Laboratories International Srl | Sedative Formulierungen ohne Benzodiazepin |
US20030165566A1 (en) * | 2002-01-10 | 2003-09-04 | O'toole Edel | Sedative non-benzodiazepine formulations |
MXPA04006779A (es) * | 2002-01-10 | 2005-04-25 | Biovail Lab Inc | Formulaciones de sedantes no benzodiazepinicos. |
CA2503121A1 (en) * | 2002-10-25 | 2004-05-13 | Collegium Pharmaceutical, Inc. | Pulsatile release compositions of milnacipran |
JP4681843B2 (ja) * | 2004-09-30 | 2011-05-11 | 日本臓器製薬株式会社 | 固形医薬製剤 |
GB0423964D0 (en) * | 2004-10-28 | 2004-12-01 | Jagotec Ag | Dosage form |
FR2887455B1 (fr) * | 2005-06-28 | 2007-08-10 | Sanofi Aventis Sa | Formulation a liberation prolongee de principes actifs de medicaments |
EP1948132B1 (de) * | 2005-11-18 | 2009-08-05 | Synhton B.V. | Zolpidemtabletten |
AR056633A1 (es) * | 2005-12-07 | 2007-10-17 | Gador Sa | Composiciones farmaceuticas de agentes hipnoticos de accion corta en forma de liberacion modificada y los procedimientos para preparar dichas formulaciones |
US8309104B2 (en) * | 2006-03-02 | 2012-11-13 | Watson Pharmaceuticals, Inc. | Oral controlled release formulation for sedative and hypnotic agents |
KR20070091960A (ko) * | 2006-03-08 | 2007-09-12 | 주식회사종근당 | 졸피뎀 또는 그의 염을 포함하는 안전한 제어방출형 제제조성물 |
AU2013202441B2 (en) * | 2006-04-26 | 2016-02-25 | Alphapharm Pty Ltd | Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix |
NZ703464A (en) * | 2006-04-26 | 2016-05-27 | Alphapharm Pty Ltd | Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix |
JP5275560B2 (ja) * | 2006-10-24 | 2013-08-28 | 小林化工株式会社 | 酒石酸ゾルピデム含有素錠の製造方法 |
EP1938805A1 (de) * | 2006-12-22 | 2008-07-02 | LEK Pharmaceuticals D.D. | Monolithische Zolpidemtabletten mit verzögerter Freisetzung |
EP1970056A1 (de) * | 2007-03-15 | 2008-09-17 | Polichem S.A. | Zeitspezifische Dosierformen mit verzögerter/pulsatiler Freisetzung |
WO2009021127A2 (en) * | 2007-08-07 | 2009-02-12 | Neurogen Corporation | Controlled released compositions |
PL2276473T3 (pl) | 2008-04-18 | 2017-03-31 | Intec Pharma Ltd. | Podawanie leku karbidopa/lewodopa o przedłużonej retencji w żołądku |
US20100068283A1 (en) | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Ex VIVO modifiable particle or polymeric material medicament carrier |
ES2562925T3 (es) * | 2008-12-04 | 2016-03-09 | Intec Pharma Ltd. | Sistema de administración de fármaco gastrorretentivo de zaleplón |
CN102470108A (zh) * | 2009-07-07 | 2012-05-23 | 桑诺维恩药品公司 | 非pH依赖型制剂(6-(5-氯-2-吡啶基)-5-[(4-甲基-1-哌嗪基)羰氧基]-7-氧代-6,7-二氢-5H-吡咯并[3,4-b]吡嗪) |
FR2949062B1 (fr) * | 2009-08-12 | 2011-09-02 | Debregeas Et Associes Pharma | Nouvelles formulations pharmaceutiques contre le mesusage des medicaments |
GB201003766D0 (en) | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Pulsatile drug release |
GB201003734D0 (en) | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Delayed prolonged drug delivery |
GB201003731D0 (en) | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Immediate/delayed drug delivery |
FR2968992B1 (fr) * | 2010-12-16 | 2013-02-08 | Sanofi Aventis | Comprime pharmaceutique orodispersible a base de zolpidem |
FR2968995B1 (fr) * | 2010-12-16 | 2013-03-22 | Sanofi Aventis | Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage |
TWI505841B (zh) * | 2011-09-29 | 2015-11-01 | Taiwan Biotech Co Ltd | 治療睡眠障礙之控釋調配物 |
WO2015120006A1 (en) * | 2014-02-06 | 2015-08-13 | Sequential Medicine Limited | Composition and method for aiding sleep |
RU2659200C1 (ru) * | 2017-07-24 | 2018-06-28 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Фармацевтический состав, содержащий алимемазина тартрат |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8404467D0 (sv) * | 1984-09-06 | 1984-09-06 | Ferrosan Ab | Controlled-release medical preparations |
GB2185887B (en) * | 1987-02-18 | 1989-12-06 | Farmitalia Carlo Erba Ltd | Temazepam composition |
EP0361910B1 (de) * | 1988-09-30 | 1994-06-29 | Rhone-Poulenc Rorer Limited | Pharmazeutisches Granulat |
FR2656303B1 (fr) * | 1989-12-26 | 1994-06-10 | Parke Davis | Solution buvable d'un derive des benzodiazepines et son application pharmacologique. |
IE61651B1 (en) * | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
IT1264517B1 (it) * | 1993-05-31 | 1996-09-24 | Ekita Investments Nv | Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati |
IT1276689B1 (it) * | 1995-06-09 | 1997-11-03 | Applied Pharma Res | Forma farmaceutica solida ad uso orale |
US5837284A (en) * | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
FR2742660B1 (fr) * | 1995-12-22 | 1998-04-03 | Ethypharm Lab Prod Ethiques | Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif |
HRP970493A2 (en) * | 1996-09-23 | 1998-08-31 | Wienman E. Phlips | Oral delayed immediate release medical formulation and method for preparing the same |
BR9802915A (pt) * | 1997-09-12 | 2000-01-11 | Oscar Gold | Procedimento para formar composições farmaceuticas em pilulas ou granulos substancialmente esfericos, de ação controlada e continuada, contendo como agente ativo o (7-bromo-1,3-diidro-5-(2-piridninilo)-2h-1,4-benzodiazep ina-2(1h)-um) |
US6066339A (en) * | 1997-10-17 | 2000-05-23 | Elan Corporation, Plc | Oral morphine multiparticulate formulation |
FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
EP1005863A1 (de) * | 1998-12-04 | 2000-06-07 | Synthelabo | Dosisformen mit gesteuerter Wirkstofffreigabe enthaltend ein kurzer wirkung Hypnotikum oder einem Salz davon |
-
1999
- 1999-06-28 EP EP99401605A patent/EP1064937A1/de not_active Withdrawn
-
2000
- 2000-06-27 IL IL14692800A patent/IL146928A0/xx not_active IP Right Cessation
- 2000-06-27 CA CA002370556A patent/CA2370556C/en not_active Expired - Fee Related
- 2000-06-27 DE DE60011617T patent/DE60011617T2/de not_active Expired - Lifetime
- 2000-06-27 SK SK1911-2001A patent/SK285347B6/sk not_active IP Right Cessation
- 2000-06-27 AR ARP000103214A patent/AR024491A1/es unknown
- 2000-06-27 MX MXPA01013212A patent/MXPA01013212A/es active IP Right Grant
- 2000-06-27 PL PL357348A patent/PL201777B1/pl unknown
- 2000-06-27 DK DK00954518T patent/DK1194132T3/da active
- 2000-06-27 BR BR0011994-6A patent/BR0011994A/pt not_active Application Discontinuation
- 2000-06-27 AT AT00954518T patent/ATE269062T1/de active
- 2000-06-27 ES ES00954518T patent/ES2222223T3/es not_active Expired - Lifetime
- 2000-06-27 AU AU66944/00A patent/AU782162B2/en not_active Ceased
- 2000-06-27 HU HU0201907A patent/HU227810B1/hu not_active IP Right Cessation
- 2000-06-27 WO PCT/EP2000/006792 patent/WO2001000181A2/en active IP Right Grant
- 2000-06-27 CO CO00048052A patent/CO5190680A1/es active IP Right Grant
- 2000-06-27 NZ NZ515997A patent/NZ515997A/xx not_active IP Right Cessation
- 2000-06-27 TR TR2001/03594T patent/TR200103594T2/xx unknown
- 2000-06-27 KR KR1020017016730A patent/KR20020015064A/ko not_active Application Discontinuation
- 2000-06-27 CZ CZ20014640A patent/CZ20014640A3/cs unknown
- 2000-06-27 EP EP00954518A patent/EP1194132B1/de not_active Expired - Lifetime
- 2000-06-27 SI SI200030461T patent/SI1194132T1/xx unknown
- 2000-06-27 PT PT00954518T patent/PT1194132E/pt unknown
- 2000-06-27 JP JP2001505891A patent/JP2003503340A/ja active Pending
- 2000-06-27 CN CNB00809487XA patent/CN100415216C/zh not_active Expired - Fee Related
- 2000-06-29 TW TW089112860A patent/TWI285118B/zh not_active IP Right Cessation
-
2001
- 2001-12-05 ZA ZA200110005A patent/ZA200110005B/xx unknown
- 2001-12-20 NO NO20016283A patent/NO20016283L/no unknown
-
2002
- 2002-06-24 HK HK02104684.1A patent/HK1043057B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE269062T1 (de) | Zeitgesteuert freisetzende dosierungsformen enthaltend ein kurz wirksames hypnotikum oder ein salz davon | |
NO2013004I2 (no) | Axitinib, valgfritt i form av et farmasøytisk aksentabelt salt | |
DK1135125T3 (da) | Doseringsformer med reguleret frigivelse omfattende zolpidem eller et salt deraf | |
NO20022970L (no) | Hydrogel-drevet medikamentdoseringsform | |
NO20020464L (no) | Flerkomponents farmasöytisk doseringsform | |
PT1307457E (pt) | Compostos heterociclicos sua preparacao e utilizacao como medicamentos noemadamente como antibacterianos | |
NO996085L (no) | Dispenser med doseringsteller | |
HU0004123D0 (en) | New compounds with pharmaceutical activity | |
ATE352339T1 (de) | Medikamentspender | |
DE69928777D1 (de) | Dosierspender | |
FIU20000164U0 (fi) | Uusi farmaseuttinen formulaatio | |
DE60010824T2 (de) | Katheter zur intermittierenden Selbst-Ableitung von Urin | |
EE200300055A (et) | Hüdrogeeli poolt juhitav ravimi annustamisvorm | |
ATE267178T1 (de) | Diazepinderivate oder deren salze | |
EE200200012A (et) | Suukaudselt manustatav maskeeritud maitsega vedelpreparaat | |
ATE419231T1 (de) | Mono-substituierte 3-propyl-gamma- aminobuttersäure | |
DK79098A (da) | Selvborende dyvel | |
NO20014926L (no) | Farmasöytiske forbindelser | |
DE60045592D1 (de) | Benachbart montierbare Sensoreinheit | |
DE60037638D1 (de) | Zeitmessgerät | |
ATE237529T1 (de) | Tablettenspender | |
DE69903293D1 (de) | Überrollsensor mit nebenschluss | |
ATE294804T1 (de) | Pharmazeutische zusammensetzung enthaltend ein farnesyl-transferase hemmenden 1,2-annellierten chinolin enantiomer | |
DE10054221B4 (de) | Verdampfungselement zum Eindampfen einer Flüssigkeit in ein Gas | |
EE200100697A (et) | Farmatseutiline kompleks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1194132 Country of ref document: EP |